Terrence Purnell is a longtime clinical quality assurance professional who served as associate director with Takeda Pharmaceutical. Based in Massachusetts, he assisted clinical development teams in meeting good clinical practice mandates. He worked to identify compliance issues before they become major problems and recommended practical risk mitigation strategies. Terrence Purnell also took part in due diligence and process improvement initiatives.
Mr. Purnell’s professional background includes a quality assurance auditor position with ICON Clinical Research, where he supported customer audits and regulatory authority inspections. He ensured that data was properly recorded and formally reported and documented using TrackWise. He also providing ICON staff with training support related to good clinical practices, regulator actions, and quality assurance.
Mr. Purnell holds a master’s degree in pharmacology from Thomas Jefferson University, with a clinical practice emphasis. His thesis centered on small non-coding RNAs known as microRNAs (miRNAs), which are implicated in the development of various types of cancer. His research identified a potential connection between miRNAs and the development of solid tumors.